
Pharmacally
Parkinson’s Disease
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Parkinson’s Disease
Mergers & AcquisitionsAlector Signs $1.27 Billion Genentech Deal for Parkinson’s Disease Therapy AL050Alector has granted Genentech worldwide rights to its preclinical AL050 GCase enzyme replacement therapy for Parkinson’s disease.Fact-Checked
New Drug ApprovalAbbVie’s Jumvo (Tavapadon) Receives FDA Approval for Parkinson’s DiseaseAbbVie’s tavapadon (Juvmo) has received FDA approval for adults with Parkinson’s disease. The once-daily D1/D5 dopamine receptor agonist demonstrated improvements in motor function and ON time across the…Fact-Checked
Health TidingsACI-7104 Shows 100% Antibody Response in Phase 2 Parkinson’s Disease TrialAC Immune’s ACI-7104 met all primary endpoints in a Phase 2 Parkinson’s disease trial, with 100% antibody response and CSF penetration.Fact-Checked
Health TidingsRemepy Advances Hybridopa Toward Phase III After Positive Parkinson’s Disease Phase IIa ResultsRemepy is preparing global Phase III development of Hybridopa for Parkinson’s disease after Phase IIa results showed improvements in motor and non-motor symptoms.Fact-Checked
Health TidingsFDA Grants Fast Track Designation to AC Immune’s ACI-7104 for Parkinson DiseaseAC Immune’s ACI-7104 received FDA Fast Track designation and IND clearance for early Parkinson’s disease. The anti-alpha-synuclein active immunotherapy showed a 100% immunogenicity responder rate with favorable safety…Fact-Checked
Health TidingsTavapadon Significantly Improved Motor Symptoms in Phase 3 Trial for Early Parkinson’s DiseaseResults from the Phase 3 TEMPO-2 trial show that tavapadon, a once-daily selective D1/D5 receptor agonist, significantly improved motor symptoms and daily functioning in early Parkinson’s disease with…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.